Clinical Trial

Clinical Outcomes of Indocyanine Green Tracer Using in Laparoscopic Gastrectomy With Lymph Node Dissection for Remnant Gastric Cancer

Recruiting Phase 2
View on ClinicalTrials.gov →
Record status
This record was last updated November 16, 2022 (before its estimated April 1, 2025 completion). Its status may not reflect the trial's current state.
Summary
Patients with resectable remnant gastric cancer were selected as study subjects to investigate the safety, efficacy, and feasibility of ICG near-infrared imaging tracing in guiding laparoscopic lymph node dissection for remnant gastric cancer by comparing injection ICG group and non-injection ICG group.
Trial Details
NCT Number NCT05618821
Lead Sponsor Fujian Medical University
Conditions Gastric Cancer
Enrollment 68 participants
Start Date 2022-06-03
Primary Completion 2025-04-01 (estimated)
Study Completion 2028-04-01 (estimated)
Updated on ClinicalTrials.gov 2022-11-16